Jump to content

Search results

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • Thumbnail for Variant of uncertain significance
    associated with a disease, it is called a "pathogenic variant". A "pharmacogenomic variant" has an effect only when an individual takes a particular drug...
    23 KB (2,275 words) - 11:29, 23 June 2024
  • Thumbnail for Pharmacogenomics
    Pharmacogenomics, often abbreviated "PGx," is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining...
    63 KB (6,671 words) - 01:29, 1 June 2024
  • Thumbnail for Cancer pharmacogenomics
    subset of the broader field of pharmacogenomics, which is the area of study aimed at understanding how genetic variants influence drug efficacy and toxicity...
    36 KB (4,062 words) - 06:00, 17 June 2024
  • Thumbnail for Geisinger Health System
    of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics". Genes. 11 (5): 561. doi:10.3390/genes11050561...
    29 KB (2,132 words) - 15:37, 2 September 2024
  • The Pharmacogenomics Knowledgebase (PharmGKB) is a publicly available, online knowledge base responsible for the aggregation, curation, integration and...
    16 KB (1,762 words) - 01:29, 22 November 2022
  • Thumbnail for Single-nucleotide polymorphism
    treatment. Genome-wide pharmacogenetic study is called pharmacogenomics. Pharmacogenetics and pharmacogenomics are important in the development of precision medicine...
    58 KB (6,238 words) - 03:17, 12 August 2024
  • Thumbnail for CYP2C9
    Pathology Pharmacogenomics (PGx) Working Group in 2019 has recommended a minimum panel of variant alleles (Tier 1) and an extended panel of variant alleles...
    50 KB (5,023 words) - 03:04, 8 April 2024
  • Thumbnail for Irinotecan
    In 2005, the FDA made changes to the labeling of irinotecan to add pharmacogenomics recommendations, such that irinotecan recipients with a homozygous...
    26 KB (2,315 words) - 04:55, 13 April 2024
  • Thumbnail for CYP2D6
    possessing certain allelic variants will show normal, decreased, or no CYP2D6 function, depending on the allele. Pharmacogenomic tests are now available...
    47 KB (3,786 words) - 16:10, 12 July 2024
  • statin. In 2015, a pharmacogenomic sub-study of the dal-OUTCOMES clinical trial on 5,749 individuals identified a genetic variant in the ADCY9 gene which...
    9 KB (790 words) - 14:01, 11 July 2024
  • Thumbnail for Frameshift mutation
    Wiskott–Aldrich syndrome, and Bloom syndrome. There are no drugs or other pharmacogenomic methods that help with PIDs. A European patent (EP1369126A1) in 2003...
    36 KB (4,730 words) - 03:35, 14 August 2024
  • Thumbnail for Dominance (genetics)
    is the phenomenon of one variant (allele) of a gene on a chromosome masking or overriding the effect of a different variant of the same gene on the other...
    24 KB (2,497 words) - 23:00, 29 August 2024
  • Thumbnail for Gene polymorphism
    Research, Center for Drug Evaluation and (2024-02-02). "Table of Pharmacogenomic Biomarkers in Drug Labeling". FDA. "Genomics and Medicine". www.genome...
    21 KB (2,521 words) - 19:20, 28 August 2024
  • Scaria, Vinod (2018). "Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences". The Pharmacogenomics Journal. 18 (4): 590–600...
    4 KB (415 words) - 19:24, 21 June 2021
  • Thumbnail for CYP2C19
    these three variant alleles to be included in the minimal clinical pharmacogenomic testing panel, called tier 1. The extended panel of variant alleles, called...
    39 KB (3,879 words) - 02:14, 11 August 2024
  • Thumbnail for DbSNP
    given site of interest. In addition, dbSNP guides applied research in pharmacogenomics and the association of genetic variation with phenotypic traits. According...
    21 KB (2,140 words) - 21:38, 2 December 2023
  • Thumbnail for SN-38
    diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy". J. Clin. Oncol. 24 (28): 4534–8. doi:10...
    3 KB (225 words) - 16:48, 11 January 2024
  • trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics". PLOS Computational Biology. 9 (12): e1003405. Bibcode:2013PLSCB....
    19 KB (2,138 words) - 19:36, 13 March 2024
  • Thumbnail for Human variability
    international collaboration to catalogue human genetic variation". Pharmacogenomics. 7 (7): 969–72. doi:10.2217/14622416.7.7.969. PMID 17054407. "random...
    47 KB (5,469 words) - 18:21, 3 August 2024
  • locus in Caucasian patients with carbamazepine hypersensitivity". Pharmacogenomics. 7 (6): 813–8. doi:10.2217/14622416.7.6.813. PMID 16981842.{{cite journal}}:...
    56 KB (5,844 words) - 03:24, 2 September 2024
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)